674 related articles for article (PubMed ID: 22752934)
1. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
Chirasani SR; Leukel P; Gottfried E; Hochrein J; Stadler K; Neumann B; Oefner PJ; Gronwald W; Bogdahn U; Hau P; Kreutz M; Grauer OM
Int J Cancer; 2013 Feb; 132(4):843-53. PubMed ID: 22752934
[TBL] [Abstract][Full Text] [Related]
2. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
Fecci PE; Sweeney AE; Grossi PM; Nair SK; Learn CA; Mitchell DA; Cui X; Cummings TJ; Bigner DD; Gilboa E; Sampson JH
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4294-305. PubMed ID: 16857805
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
4. Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
Grauer OM; Sutmuller RP; van Maren W; Jacobs JF; Bennink E; Toonen LW; Nierkens S; Adema GJ
Int J Cancer; 2008 Apr; 122(8):1794-802. PubMed ID: 18076066
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
6. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma.
Akasaki Y; Liu G; Chung NH; Ehtesham M; Black KL; Yu JS
J Immunol; 2004 Oct; 173(7):4352-9. PubMed ID: 15383564
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen and Diclofenac Restrict Migration and Proliferation of Human Glioma Cells by Distinct Molecular Mechanisms.
Leidgens V; Seliger C; Jachnik B; Welz T; Leukel P; Vollmann-Zwerenz A; Bogdahn U; Kreutz M; Grauer OM; Hau P
PLoS One; 2015; 10(10):e0140613. PubMed ID: 26485029
[TBL] [Abstract][Full Text] [Related]
8. CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.
Grauer OM; Nierkens S; Bennink E; Toonen LW; Boon L; Wesseling P; Sutmuller RP; Adema GJ
Int J Cancer; 2007 Jul; 121(1):95-105. PubMed ID: 17315190
[TBL] [Abstract][Full Text] [Related]
9. Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells.
Dumitriu IE; Dunbar DR; Howie SE; Sethi T; Gregory CD
J Immunol; 2009 Mar; 182(5):2795-807. PubMed ID: 19234174
[TBL] [Abstract][Full Text] [Related]
10. Site-specific anti-tumor immunity: differences in DC function, TGF-beta production and numbers of intratumoral Foxp3+ Treg.
Biollaz G; Bernasconi L; Cretton C; Püntener U; Frei K; Fontana A; Suter T
Eur J Immunol; 2009 May; 39(5):1323-33. PubMed ID: 19337997
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.
Husain Z; Huang Y; Seth P; Sukhatme VP
J Immunol; 2013 Aug; 191(3):1486-95. PubMed ID: 23817426
[TBL] [Abstract][Full Text] [Related]
12. Enhanced T-cell responses to glioma cells coated with the anti-EGF receptor antibody and targeted to activating FcgammaRs on human dendritic cells.
Banerjee D; Matthews P; Matayeva E; Kaufman JL; Steinman RM; Dhodapkar KM
J Immunother; 2008; 31(2):113-20. PubMed ID: 18481381
[TBL] [Abstract][Full Text] [Related]
13. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
14. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone counteracts the immunostimulatory effects of triiodothyronine (T3) on dendritic cells.
Montesinos MM; Alamino VA; Mascanfroni ID; Susperreguy S; Gigena N; Masini-Repiso AM; Rabinovich GA; Pellizas CG
Steroids; 2012 Jan; 77(1-2):67-76. PubMed ID: 22056479
[TBL] [Abstract][Full Text] [Related]
16. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
17. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.
Grauer O; Pöschl P; Lohmeier A; Adema GJ; Bogdahn U
J Neurooncol; 2007 Apr; 82(2):151-61. PubMed ID: 17106649
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
Chen X; Du Y; Huang Z
Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4⁺CD25⁺Foxp3⁺ regulatory T cells.
Huang Y; Zhao Y; Ran X; Wang C
Mol Med Rep; 2014 Mar; 9(3):813-8. PubMed ID: 24366217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
